| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 91 | 2023 | 535 | 22.290 |
Why?
|
| Chromatin | 38 | 2023 | 428 | 9.520 |
Why?
|
| Nucleosomes | 18 | 2022 | 122 | 6.580 |
Why?
|
| Histone Acetyltransferases | 16 | 2023 | 51 | 6.290 |
Why?
|
| Lysine | 29 | 2023 | 242 | 6.080 |
Why?
|
| DNA-Binding Proteins | 33 | 2023 | 1318 | 6.080 |
Why?
|
| Protein Processing, Post-Translational | 31 | 2022 | 399 | 5.810 |
Why?
|
| Epigenesis, Genetic | 22 | 2022 | 524 | 5.750 |
Why?
|
| Protein Domains | 21 | 2022 | 207 | 5.230 |
Why?
|
| Transcription Factors | 28 | 2023 | 1531 | 4.340 |
Why?
|
| Protein Binding | 64 | 2023 | 1898 | 4.270 |
Why?
|
| PHD Zinc Fingers | 8 | 2023 | 12 | 4.250 |
Why?
|
| Nuclear Proteins | 15 | 2022 | 593 | 4.150 |
Why?
|
| Models, Molecular | 49 | 2021 | 1379 | 4.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 13 | 2023 | 333 | 3.750 |
Why?
|
| Protein Structure, Tertiary | 45 | 2017 | 798 | 3.480 |
Why?
|
| Adenosine Triphosphatases | 6 | 2020 | 155 | 3.070 |
Why?
|
| Transcription Factor TFIID | 6 | 2023 | 21 | 2.820 |
Why?
|
| Binding Sites | 37 | 2022 | 1173 | 2.800 |
Why?
|
| Acetylation | 28 | 2023 | 211 | 2.790 |
Why?
|
| Phosphatidylinositol Phosphates | 16 | 2011 | 38 | 2.740 |
Why?
|
| Histone-Lysine N-Methyltransferase | 10 | 2023 | 95 | 2.680 |
Why?
|
| Methylation | 33 | 2023 | 208 | 2.520 |
Why?
|
| Crystallography, X-Ray | 24 | 2021 | 405 | 2.470 |
Why?
|
| Homeodomain Proteins | 16 | 2020 | 464 | 2.420 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 9 | 2017 | 24 | 2.420 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2023 | 139 | 2.270 |
Why?
|
| Histone Code | 10 | 2019 | 28 | 2.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2021 | 370 | 2.010 |
Why?
|
| DNA | 15 | 2022 | 1352 | 1.930 |
Why?
|
| Magnetic Resonance Spectroscopy | 20 | 2022 | 482 | 1.920 |
Why?
|
| Tumor Suppressor Proteins | 12 | 2013 | 282 | 1.800 |
Why?
|
| DNA Methylation | 8 | 2020 | 496 | 1.790 |
Why?
|
| Epigenomics | 3 | 2020 | 103 | 1.780 |
Why?
|
| DNA Helicases | 5 | 2023 | 133 | 1.770 |
Why?
|
| Protein Conformation | 21 | 2021 | 811 | 1.710 |
Why?
|
| Zinc Fingers | 6 | 2020 | 44 | 1.640 |
Why?
|
| Amino Acid Sequence | 31 | 2021 | 1990 | 1.590 |
Why?
|
| Autophagy | 5 | 2022 | 234 | 1.550 |
Why?
|
| Humans | 125 | 2023 | 115042 | 1.420 |
Why?
|
| Mitosis | 3 | 2017 | 164 | 1.420 |
Why?
|
| Protein Interaction Domains and Motifs | 10 | 2020 | 132 | 1.420 |
Why?
|
| HEK293 Cells | 12 | 2021 | 590 | 1.280 |
Why?
|
| Translocation, Genetic | 4 | 2023 | 94 | 1.220 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 18 | 2021 | 238 | 1.220 |
Why?
|
| Phosphatidylinositols | 7 | 2012 | 53 | 1.210 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 447 | 1.200 |
Why?
|
| Cell Cycle Proteins | 8 | 2022 | 551 | 1.190 |
Why?
|
| Molecular Sequence Data | 25 | 2015 | 2796 | 1.190 |
Why?
|
| Polycomb-Group Proteins | 7 | 2023 | 29 | 1.120 |
Why?
|
| Multiprotein Complexes | 3 | 2018 | 141 | 1.110 |
Why?
|
| Drug Design | 2 | 2020 | 151 | 1.100 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2023 | 477 | 1.070 |
Why?
|
| Sequestosome-1 Protein | 4 | 2022 | 13 | 1.060 |
Why?
|
| Membrane Proteins | 11 | 2012 | 1019 | 1.050 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2018 | 59 | 1.040 |
Why?
|
| Gene Expression Regulation | 12 | 2023 | 2329 | 1.000 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2022 | 88 | 1.000 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 342 | 1.000 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 334 | 0.990 |
Why?
|
| Calixarenes | 2 | 2015 | 6 | 0.980 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 386 | 0.950 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2021 | 8 | 0.950 |
Why?
|
| Ubiquitin | 2 | 2022 | 57 | 0.940 |
Why?
|
| Drosophila Proteins | 3 | 2017 | 163 | 0.940 |
Why?
|
| SUMO-1 Protein | 2 | 2020 | 19 | 0.900 |
Why?
|
| Diet | 2 | 2022 | 1076 | 0.880 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2023 | 42 | 0.880 |
Why?
|
| DNA Replication | 2 | 2023 | 202 | 0.870 |
Why?
|
| Acetyltransferases | 1 | 2023 | 20 | 0.850 |
Why?
|
| Thiazoles | 1 | 2023 | 110 | 0.850 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 3 | 2018 | 12 | 0.840 |
Why?
|
| Leukemia | 2 | 2023 | 209 | 0.840 |
Why?
|
| Polyphenols | 1 | 2022 | 16 | 0.830 |
Why?
|
| Repressor Proteins | 4 | 2018 | 368 | 0.820 |
Why?
|
| Cell Nucleus | 3 | 2023 | 556 | 0.820 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2022 | 15 | 0.820 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2020 | 54 | 0.810 |
Why?
|
| Proteins | 3 | 2020 | 915 | 0.800 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2011 | 193 | 0.770 |
Why?
|
| Histidine | 7 | 2017 | 57 | 0.770 |
Why?
|
| Acute Disease | 2 | 2021 | 915 | 0.770 |
Why?
|
| Animals | 36 | 2023 | 31867 | 0.770 |
Why?
|
| Mutation | 11 | 2020 | 3350 | 0.740 |
Why?
|
| DNA Repair | 6 | 2019 | 186 | 0.730 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2020 | 3 | 0.730 |
Why?
|
| Vesicular Transport Proteins | 9 | 2009 | 83 | 0.720 |
Why?
|
| Oligopeptides | 1 | 2022 | 234 | 0.720 |
Why?
|
| Immune Evasion | 1 | 2020 | 47 | 0.710 |
Why?
|
| Betacoronavirus | 2 | 2020 | 253 | 0.710 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2020 | 31 | 0.710 |
Why?
|
| Biochemistry | 1 | 2020 | 40 | 0.710 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 2715 | 0.710 |
Why?
|
| Leukemia, Myeloid | 1 | 2020 | 40 | 0.710 |
Why?
|
| Macromolecular Substances | 1 | 2020 | 200 | 0.700 |
Why?
|
| Enzymes | 1 | 2020 | 62 | 0.690 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1879 | 0.690 |
Why?
|
| Immunity, Innate | 2 | 2022 | 723 | 0.690 |
Why?
|
| Phase Transition | 1 | 2019 | 25 | 0.690 |
Why?
|
| p300-CBP Transcription Factors | 2 | 2019 | 15 | 0.670 |
Why?
|
| Membrane Lipids | 3 | 2012 | 87 | 0.670 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 93 | 0.660 |
Why?
|
| Viral Vaccines | 1 | 2020 | 89 | 0.660 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2020 | 157 | 0.650 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 40 | 0.650 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2020 | 179 | 0.650 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2020 | 59 | 0.640 |
Why?
|
| Heterochromatin | 2 | 2016 | 32 | 0.620 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 534 | 0.610 |
Why?
|
| Antigens, Neoplasm | 2 | 2016 | 222 | 0.610 |
Why?
|
| Protein Structure, Secondary | 5 | 2013 | 325 | 0.600 |
Why?
|
| Histone Deacetylases | 3 | 2016 | 196 | 0.590 |
Why?
|
| Ligands | 5 | 2021 | 565 | 0.580 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2014 | 100 | 0.580 |
Why?
|
| Pyrans | 1 | 2017 | 3 | 0.570 |
Why?
|
| Cell Plasticity | 1 | 2017 | 23 | 0.570 |
Why?
|
| Neoplasms | 6 | 2023 | 2106 | 0.570 |
Why?
|
| Mutagenesis, Site-Directed | 10 | 2021 | 345 | 0.560 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 36 | 0.560 |
Why?
|
| Transcription, Genetic | 10 | 2020 | 1317 | 0.550 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2016 | 62 | 0.550 |
Why?
|
| Histidine Kinase | 1 | 2016 | 33 | 0.550 |
Why?
|
| Protein Folding | 4 | 2017 | 239 | 0.540 |
Why?
|
| Molecular Dynamics Simulation | 5 | 2020 | 201 | 0.540 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 1144 | 0.540 |
Why?
|
| Morpholines | 1 | 2017 | 101 | 0.540 |
Why?
|
| Thiophenes | 1 | 2017 | 108 | 0.530 |
Why?
|
| Autoantigens | 4 | 2014 | 397 | 0.530 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 385 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 115 | 0.520 |
Why?
|
| Molecular Structure | 7 | 2021 | 438 | 0.520 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2023 | 786 | 0.510 |
Why?
|
| Antiviral Agents | 2 | 2022 | 647 | 0.510 |
Why?
|
| Cell Membrane | 4 | 2012 | 681 | 0.510 |
Why?
|
| Pandemics | 2 | 2020 | 1321 | 0.510 |
Why?
|
| Fluorescence Polarization | 3 | 2021 | 35 | 0.500 |
Why?
|
| Inositol Phosphates | 2 | 2012 | 23 | 0.500 |
Why?
|
| Carrier Proteins | 2 | 2018 | 696 | 0.500 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1045 | 0.490 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 2 | 2021 | 5 | 0.490 |
Why?
|
| Plant Proteins | 1 | 2015 | 81 | 0.490 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 524 | 0.480 |
Why?
|
| Phosphorylation | 7 | 2016 | 1572 | 0.480 |
Why?
|
| Signal Transduction | 8 | 2023 | 4525 | 0.480 |
Why?
|
| Lipid Bilayers | 4 | 2011 | 99 | 0.480 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 99 | 0.460 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2018 | 353 | 0.450 |
Why?
|
| Influenza, Human | 1 | 2019 | 546 | 0.440 |
Why?
|
| Molecular Docking Simulation | 3 | 2020 | 102 | 0.430 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 57 | 0.410 |
Why?
|
| Cyclophilins | 2 | 2023 | 29 | 0.400 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2017 | 512 | 0.400 |
Why?
|
| Mice | 15 | 2023 | 14927 | 0.390 |
Why?
|
| Micelles | 4 | 2006 | 34 | 0.390 |
Why?
|
| Molecular Probes | 1 | 2011 | 30 | 0.390 |
Why?
|
| HMGN2 Protein | 1 | 2011 | 3 | 0.390 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 1237 | 0.390 |
Why?
|
| Intracellular Membranes | 2 | 2011 | 73 | 0.380 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2011 | 4 | 0.380 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 11 | 0.380 |
Why?
|
| Static Electricity | 4 | 2020 | 114 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 331 | 0.370 |
Why?
|
| RNA | 2 | 2023 | 810 | 0.370 |
Why?
|
| Molecular Conformation | 2 | 2022 | 137 | 0.370 |
Why?
|
| Sequence Alignment | 8 | 2015 | 325 | 0.370 |
Why?
|
| Qc-SNARE Proteins | 3 | 2006 | 7 | 0.360 |
Why?
|
| Viral Proteins | 2 | 2022 | 281 | 0.360 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2020 | 616 | 0.350 |
Why?
|
| CpG Islands | 2 | 2023 | 118 | 0.350 |
Why?
|
| Models, Biological | 7 | 2020 | 1636 | 0.340 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 36 | 0.340 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2021 | 32 | 0.330 |
Why?
|
| Peptides | 6 | 2020 | 849 | 0.330 |
Why?
|
| Acylation | 2 | 2019 | 28 | 0.330 |
Why?
|
| Cell Line | 9 | 2018 | 2645 | 0.330 |
Why?
|
| Catalytic Domain | 3 | 2019 | 197 | 0.330 |
Why?
|
| Escherichia coli | 4 | 2020 | 719 | 0.310 |
Why?
|
| Conserved Sequence | 5 | 2013 | 218 | 0.310 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 503 | 0.310 |
Why?
|
| Ubiquitination | 2 | 2019 | 86 | 0.310 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2007 | 24 | 0.310 |
Why?
|
| Carcinogenesis | 2 | 2021 | 178 | 0.300 |
Why?
|
| Genetic Therapy | 1 | 2009 | 258 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 529 | 0.300 |
Why?
|
| Kinetics | 3 | 2020 | 1558 | 0.300 |
Why?
|
| Amino Acid Motifs | 7 | 2020 | 198 | 0.300 |
Why?
|
| HeLa Cells | 7 | 2017 | 562 | 0.300 |
Why?
|
| Small Molecule Libraries | 2 | 2021 | 80 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 311 | 0.290 |
Why?
|
| Apoptosis | 3 | 2023 | 2366 | 0.290 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 4 | 2015 | 176 | 0.290 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2007 | 45 | 0.290 |
Why?
|
| CREB-Binding Protein | 2 | 2019 | 27 | 0.290 |
Why?
|
| Methyltransferases | 2 | 2019 | 61 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 697 | 0.270 |
Why?
|
| Cell Cycle | 2 | 2020 | 544 | 0.270 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 20 | 0.270 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1700 | 0.270 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 16 | 0.260 |
Why?
|
| Substrate Specificity | 7 | 2013 | 355 | 0.260 |
Why?
|
| Crystallization | 2 | 2020 | 136 | 0.250 |
Why?
|
| Tryptophan | 3 | 2020 | 135 | 0.250 |
Why?
|
| Cytosol | 2 | 2021 | 208 | 0.250 |
Why?
|
| DNA Damage | 4 | 2015 | 357 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 7 | 2020 | 1133 | 0.240 |
Why?
|
| Protein Subunits | 3 | 2014 | 201 | 0.240 |
Why?
|
| Endosomes | 2 | 2005 | 124 | 0.230 |
Why?
|
| Cloning, Molecular | 2 | 2020 | 524 | 0.230 |
Why?
|
| Phosphatidylethanolamines | 3 | 2011 | 66 | 0.230 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2023 | 18 | 0.220 |
Why?
|
| Tudor Domain | 3 | 2021 | 3 | 0.220 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 49 | 0.220 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2023 | 40 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2021 | 3896 | 0.220 |
Why?
|
| Homologous Recombination | 1 | 2023 | 20 | 0.220 |
Why?
|
| Biophysical Phenomena | 2 | 2021 | 63 | 0.210 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 191 | 0.210 |
Why?
|
| Plants | 2 | 2023 | 202 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 134 | 0.190 |
Why?
|
| Databases, Protein | 1 | 2021 | 59 | 0.190 |
Why?
|
| Peptidomimetics | 1 | 2021 | 2 | 0.190 |
Why?
|
| K562 Cells | 2 | 2019 | 73 | 0.190 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 176 | 0.190 |
Why?
|
| Zinc Finger Nucleases | 1 | 2020 | 1 | 0.190 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2021 | 74 | 0.190 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2020 | 3 | 0.190 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2020 | 5 | 0.190 |
Why?
|
| GATA4 Transcription Factor | 1 | 2020 | 17 | 0.190 |
Why?
|
| Buffers | 1 | 2020 | 53 | 0.180 |
Why?
|
| Chemical Fractionation | 1 | 2020 | 28 | 0.180 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.180 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2020 | 3 | 0.180 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 14 | 0.180 |
Why?
|
| Antigens, Nuclear | 1 | 2020 | 19 | 0.180 |
Why?
|
| Disulfiram | 1 | 2020 | 13 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 180 | 0.180 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2020 | 6 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2021 | 124 | 0.180 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 61 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 53 | 0.180 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 60 | 0.180 |
Why?
|
| Fluorescence | 1 | 2020 | 148 | 0.180 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 81 | 0.170 |
Why?
|
| Phosphoproteins | 2 | 2016 | 298 | 0.170 |
Why?
|
| Phosphatidylcholines | 2 | 2011 | 133 | 0.170 |
Why?
|
| Virulence | 1 | 2020 | 228 | 0.170 |
Why?
|
| E2F1 Transcription Factor | 1 | 2019 | 57 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2191 | 0.170 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 30 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1857 | 0.170 |
Why?
|
| Genetic Vectors | 1 | 2020 | 291 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 271 | 0.160 |
Why?
|
| Synaptosomal-Associated Protein 25 | 4 | 2006 | 25 | 0.160 |
Why?
|
| Binding, Competitive | 1 | 2019 | 195 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 99 | 0.160 |
Why?
|
| Protein Transport | 4 | 2005 | 398 | 0.160 |
Why?
|
| Drosophila | 2 | 2017 | 133 | 0.160 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 2201 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 182 | 0.160 |
Why?
|
| Sumoylation | 1 | 2018 | 15 | 0.150 |
Why?
|
| Life Expectancy | 1 | 2018 | 51 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 128 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 95 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 448 | 0.150 |
Why?
|
| Catalysis | 1 | 2019 | 292 | 0.150 |
Why?
|
| Phosphoric Monoester Hydrolases | 3 | 2010 | 54 | 0.150 |
Why?
|
| Cell Survival | 2 | 2021 | 1022 | 0.150 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 284 | 0.140 |
Why?
|
| Xenopus | 1 | 2017 | 98 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2019 | 791 | 0.140 |
Why?
|
| Arginine | 2 | 2023 | 238 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 963 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 448 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 430 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 337 | 0.140 |
Why?
|
| Aspartic Acid | 1 | 2016 | 78 | 0.140 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 143 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 152 | 0.130 |
Why?
|
| Life Style | 1 | 2018 | 431 | 0.130 |
Why?
|
| Protein Multimerization | 2 | 2015 | 160 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2017 | 132 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 799 | 0.130 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 95 | 0.130 |
Why?
|
| Histocompatibility Antigens | 1 | 2016 | 100 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 373 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 78 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 352 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 174 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2017 | 631 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 59 | 0.120 |
Why?
|
| Gene Expression | 1 | 2020 | 1423 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 157 | 0.120 |
Why?
|
| Human papillomavirus 18 | 1 | 2015 | 14 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 25 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 121 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1084 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2016 | 211 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 634 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 345 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 80 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 208 | 0.120 |
Why?
|
| Algorithms | 1 | 2021 | 1488 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1634 | 0.120 |
Why?
|
| Spermatogenesis | 1 | 2014 | 52 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1955 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 1865 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 3545 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1715 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 157 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2016 | 812 | 0.110 |
Why?
|
| Dimerization | 2 | 2006 | 176 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 105 | 0.100 |
Why?
|
| Spindle Apparatus | 1 | 2013 | 87 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 212 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2016 | 335 | 0.100 |
Why?
|
| Eukaryota | 1 | 2012 | 47 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 171 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2011 | 170 | 0.090 |
Why?
|
| Escherichia coli Proteins | 2 | 2003 | 162 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 668 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 722 | 0.090 |
Why?
|
| Phospholipids | 1 | 2011 | 199 | 0.090 |
Why?
|
| Biological Transport | 1 | 2011 | 372 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 115 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 226 | 0.090 |
Why?
|
| Genome | 1 | 2012 | 271 | 0.080 |
Why?
|
| SNARE Proteins | 2 | 2006 | 37 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2012 | 362 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 159 | 0.080 |
Why?
|
| Inhibitor of Growth Protein 1 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Pyridines | 1 | 2012 | 425 | 0.080 |
Why?
|
| Nitrogen Isotopes | 1 | 2008 | 55 | 0.080 |
Why?
|
| VDJ Recombinases | 1 | 2007 | 4 | 0.080 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2007 | 7 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 59 | 0.080 |
Why?
|
| Carbon Isotopes | 1 | 2008 | 112 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 87 | 0.070 |
Why?
|
| Protons | 1 | 2008 | 80 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2012 | 555 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 175 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2020 | 214 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 296 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2006 | 7 | 0.070 |
Why?
|
| Valine | 1 | 2006 | 72 | 0.070 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.070 |
Why?
|
| Phosphopeptides | 1 | 2006 | 15 | 0.070 |
Why?
|
| Leucine | 1 | 2006 | 107 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2006 | 33 | 0.070 |
Why?
|
| Spin Labels | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 256 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 866 | 0.060 |
Why?
|
| Mathematics | 1 | 2005 | 101 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 172 | 0.060 |
Why?
|
| Pyridones | 1 | 2006 | 125 | 0.060 |
Why?
|
| Neutrophils | 1 | 2010 | 1164 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2019 | 368 | 0.060 |
Why?
|
| Ligases | 1 | 2023 | 30 | 0.060 |
Why?
|
| Symporters | 1 | 2003 | 52 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 24 | 0.050 |
Why?
|
| Liposomes | 2 | 2007 | 146 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2023 | 17 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 19 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 872 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2020 | 839 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 586 | 0.050 |
Why?
|
| Serine | 1 | 2023 | 126 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2001 | 3 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 107 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 39 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2001 | 119 | 0.050 |
Why?
|
| Biological Assay | 1 | 2021 | 113 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 123 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2020 | 33 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 396 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 541 | 0.040 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2019 | 2 | 0.040 |
Why?
|
| DNA, Superhelical | 1 | 1999 | 11 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 123 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 61 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 138 | 0.040 |
Why?
|
| Structural Homology, Protein | 2 | 2011 | 23 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 104 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 46 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 393 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 317 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 72 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 431 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 358 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 4973 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 331 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 224 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 1999 | 311 | 0.040 |
Why?
|
| Female | 4 | 2017 | 59613 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 218 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 18 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 609 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1999 | 285 | 0.040 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 65 | 0.040 |
Why?
|
| Zinc | 1 | 1999 | 256 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2016 | 1 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 49 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 105 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 117 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 516 | 0.030 |
Why?
|
| Locus Control Region | 1 | 2015 | 2 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 396 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 315 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 131 | 0.030 |
Why?
|
| Prophase | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 4 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 349 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 59 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1036 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 51 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 928 | 0.030 |
Why?
|
| Base Sequence | 2 | 2012 | 2119 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 120 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 441 | 0.030 |
Why?
|
| CD79 Antigens | 1 | 2012 | 16 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 12 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 2012 | 10 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 14 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2012 | 50 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 56 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4718 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 138 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 156 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 228 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3419 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 264 | 0.020 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2010 | 13 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 107 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 172 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 697 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 81 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2011 | 296 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2010 | 118 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 140 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 437 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 532 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2585 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 636 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 772 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 924 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2007 | 66 | 0.020 |
Why?
|
| Metabolomics | 1 | 2012 | 527 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 23 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2006 | 33 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 1284 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 844 | 0.020 |
Why?
|
| Point Mutation | 1 | 2006 | 217 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 72 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2389 | 0.020 |
Why?
|
| Solutions | 1 | 2003 | 148 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 339 | 0.010 |
Why?
|
| Vacuoles | 1 | 2001 | 33 | 0.010 |
Why?
|
| Propanolamines | 1 | 2001 | 94 | 0.010 |
Why?
|
| Factor For Inversion Stimulation Protein | 1 | 1999 | 1 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1999 | 10 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1999 | 28 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2001 | 348 | 0.010 |
Why?
|
| DNA Gyrase | 1 | 1999 | 12 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 193 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1999 | 44 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1999 | 51 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 398 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 1149 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 2815 | 0.010 |
Why?
|
| Male | 1 | 2014 | 55731 | 0.000 |
Why?
|